Monday, January 9, 2012

Uptake Medical Raises Funding Round

Uptake Medical, the developer of treatment for emphysema, has raised a Series C round of funding, the firm said this morning. The company--which has offices in Seattle, but which recently moved its headquarters to Southern California--did not disclose the size of the Series C round, which was led by Crescent Point Group (Singapore), and also included existing investors Maverick Capital, ONSET Ventures, GBS Venture Partners, WRF Capital, Arboretum Ventures and Affinity Capital. A regulatory filing indicates the round was worth at least $35.1M, with a target size of $41.6M. Sami Sindi, Crescent Point managing partner, will join the Uptake Medical board of directors, and the company was advised by Moelis & Company in the financing round. More information »